JBT Marel Corporation reported second-quarter 2026 results that showed record orders but a messy bottom line, with net income of $28 million including a $33 million non-cash impairment charge. Orders topped $1 billion, pushing the book-to-bill ratio to 1.05x and lifting backlog to $1.54 billion, while revenue of $981 million grew 5% year over year. Adjusted EBITDA rose to $168 million, and adjusted EPS climbed to $1.95 from $1.49. The Protein Solutions segment drove growth with revenue up 11% to $467 million, but the Prepared Food and Beverage Solutions segment saw flat revenue and a margin decline due to logistics constraints. Management kept full-year revenue guidance of $3.99 billion to $4.065 billion and adjusted EBITDA margin guidance of 17% to 17.5%, but lowered GAAP diluted EPS guidance to $4.20 to $4.70. The company repurchased about 200,000 shares for $26 million under its $200 million buyback authorization, and net debt to adjusted EBITDA stood at 2.47x.
JBTMarel CorpRecord orders and higher adjusted EPS/EBITDA offset by a $33M impairment charge and lowered GAAP EPS guidance.